TMQ — Q3 2026 Financial Report Analysis

Overview

Trilogy Metals has no mines in operation and no revenue. What it owns is a 50% stake in Ambler Metals, a joint venture with mining company South32 that holds the Arctic copper-zinc project and the Bornite copper project in northwest Alaska. For the third quarter of fiscal 2026 (the three months to August 31, 2026; Trilogy's year ends November 30), the company reported net income of $0.2 million against a $1.7 million loss a year earlier. That profit came from an accounting entry, not from the business. Trilogy booked an $11.6 million non-cash gain on its agreement to issue shares to the U.S. Department of War, because its own share price fell during the quarter. Without that gain, the quarter's loss would have been about $11.3 million. Most of that was Trilogy's $9.6 million share of Ambler Metals' loss, up from $0.9 million, as the joint venture ran its biggest summer field season in years.

At a glance

• $31.2 million cash, down from $51.6 million in November. $17.0 million of the drop is Trilogy's contribution to Ambler Metals. The company's own operations used another $4.9 million over nine months.
• $9.6 million share of Ambler's loss, up from $0.9 million. This is project spending: drilling, permitting and engineering at Arctic. Ambler's nine-month loss on a 100% basis was $26.5 million, $22.3 million of it project costs.
• $17.8 million from the Department of War, received September 11. The deal closed after the quarter ended. The filing says the money has to go into Ambler Metals, so it does not pay for Trilogy's own corporate costs.

Results table

Nine months to August 31, 2026: net loss $13.2 million vs $7.5 million; loss per share $0.08 vs $0.05.

Where the money went

For an explorer like Trilogy, the key question is how fast cash goes out and on what. There are two separate streams.

1. The joint venture (the big one). Trilogy and South32 each put $17.0 million in cash into Ambler Metals during the first nine months of fiscal 2026. Trilogy's share of Ambler's 2026 budget is $17.5 million, so $0.5 million is still to come. Ambler spent the money on its 2026 summer program. That program started in mid-June and included drilling and technical work at Arctic "to support mine planning, permitting, and future development decisions," plus site preparation at Bornite. Trilogy records its half of Ambler's loss as "share of loss on equity investment." That accounting method, called the equity method, puts Trilogy's portion of the joint venture's result into its own income statement on one line. The summer season is why that line jumped from $0.9 million to $9.6 million this quarter. At August 31, Ambler held $14.8 million of its own cash, up from $3.5 million in November, so the contributions had not all been spent yet.

2. Trilogy's head office. Expenses at the parent company were $2.1 million this quarter, up from $1.2 million. Leaving out stock-based compensation (pay in shares and options, which costs no cash), they were about $1.4 million, up from $0.8 million. The biggest increases were professional fees ($643,000 vs $246,000) and salaries ($429,000 vs $251,000). The filing puts the higher salaries down to "the addition of senior staff." It does not explain the jump in professional fees. Over nine months, management says spending is within its $5.0 million corporate budget, with $1.1 million left for the fourth quarter.

The Department of War deal

In October 2025 Trilogy signed a binding letter of intent with the U.S. Department of War. The deal was extended twice, in March and May 2026, signed as a formal agreement on August 28, and closed on September 11, 2026:

• The Department bought 8,215,570 units at $2.17 each, for about $17.8 million. Each unit is one share plus three-quarters of a warrant (a right to buy more shares later).
• The warrants cover up to 6,161,678 more shares at $0.01 each. They can only be used when Phase 1 of the Ambler Access Project is finished, when the road carries at least 10 concentrate trucks within 10 days, or if Trilogy changes control. The Ambler Access Project is the proposed industrial road into the district.
• At the same time, the Department bought another 8,215,570 Trilogy shares from South32, plus a call option on 6,161,678 more.
• The Department can nominate one director and send one observer to Trilogy's board.

Trilogy had promised these shares at $2.17 before the deal was final, so its accounting treated the promise as a liability that moved with the share price. When Trilogy's stock fell, the liability shrank and the company booked a gain. In this quarter that gain was $11.6 million. At August 31 the liability was valued at $23.0 million, using a share price of $3.61 and management's view of a 50/50 chance that the Ambler road gets built. The deal closed on September 11, and the fourth quarter will show a further $3.9 million non-cash gain when the liability is settled. After that, this item stops affecting results.

What the headline numbers hide

• The profit is not real cash earnings. Without the $11.6 million derivative gain, the quarter's loss was about $11.3 million. Without the $7.8 million gain over nine months, the loss was about $20.9 million, against $7.5 million a year earlier. The gain does not involve any cash, and its size depended on Trilogy's share price falling.
• The loss is mostly spending on the project, not overhead. About 84% of the quarter's loss before the gain was Trilogy's share of Ambler's loss. The joint venture is now actively spending again, after a much lighter fiscal 2025, when Trilogy's nine-month share of its loss was just $2.2 million.
• Cash runway (how long the cash lasts) is fine for now, but it depends on the joint venture's budget. The company used $4.9 million in operations over nine months, about $1.6 million a quarter. At that rate, $31.2 million would last years. But Ambler contributions were $17.0 million this year, and the filing gives no fiscal 2027 joint venture budget. If 2027 asks for a similar amount, Trilogy's current cash covers the corporate budget plus about one more year of contributions. That is our estimate, not management's. Management says only that cash is sufficient for the next twelve months and that it "may need to raise additional funds" after that, most likely by selling shares.
• The new $17.8 million is earmarked for the project. The filing says these proceeds "do not represent additional liquidity available to fund the Company's general corporate activities." South32 will match it, so Ambler will get about $35.6 million more from both partners.
• Dilution: the number of shares keeps growing. Shares outstanding went from 171.1 million in November to 181.4 million at October 2. Most of the increase was the Department of War's 8.2 million new shares, with the rest from restricted share units and option exercises. Another 13.9 million shares could come from options and share units, plus the Department's 6.2 million warrants if the road conditions are met. Trilogy also has a $200 million at-the-market program, which lets it sell new shares into the market over time. It used $1.2 million of it in the first quarter at an average $6.83 and none since.
• Results came in below budget. The nine-month net loss of $13.2 million was below the budgeted $18.0 million. The derivative gain explains most of the gap, but "lower than planned expenditures from Ambler Metals" also helped. So the joint venture has been spending slightly less than planned, not more.

Takeaway: This quarter's small profit comes from a one-time accounting entry. What matters is that Ambler Metals is spending real money on the Arctic project again, and that the U.S. government is now a direct shareholder with $17.8 million committed to the joint venture. Trilogy's own cash ($31.2 million) is enough for now. Its longer-term funding needs depend mostly on how big Ambler's budget is each year and on whether the access road gets built.

Outlook

• Permitting: Ambler Metals began permitting for the Arctic Project in April 2026. In May, Arctic joined FAST-41, a federal program meant to coordinate and speed up permit reviews, as it moves into environmental review. Next to watch: the formal start of environmental review and its timetable.
• The Ambler road: this is still the biggest single uncertainty. Management's own valuation of the derivative gave the road even odds of being finished. The road also decides whether the Department's warrants can ever be exercised, and Trilogy says it does not control whether the road gets built.
• Funding: Q4 should bring the remaining $0.5 million of Trilogy's 2026 Ambler contribution, the $17.8 million pass-through contribution from the Department of War money, and about $1.1 million of corporate spending. Our estimate is that cash will stay in the high-$20 millions at year-end, unless Trilogy sells shares through the at-the-market program. The fiscal 2027 joint venture budget is the next number to watch. It will most likely appear with the annual 10-K, which last year was filed in mid-February.
• Our view: Trilogy is now a bet on permits and on the road, and this quarter's finances neither improve nor weaken that case. The things that would change the outlook are a FAST-41 schedule, progress on the access road, and the size of the 2027 budget. Quarterly earnings will not.